XBiotech Inc. Annual Income Tax Expense (Benefit) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
XBiotech Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • XBiotech Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$25K, a 135% decline year-over-year.
  • XBiotech Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $136K, a 95.6% decline year-over-year.
  • XBiotech Inc. annual Income Tax Expense (Benefit) for 2023 was $244K.
  • XBiotech Inc. annual Income Tax Expense (Benefit) for 2022 was -$688K, a 91.4% increase from 2021.
  • XBiotech Inc. annual Income Tax Expense (Benefit) for 2021 was -$8.04M, a 401% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $244K +$932K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$688K +$7.36M +91.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$8.04M -$6.44M -401% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 -$1.61M -$51.4M -103% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $49.8M +$49.8M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K/A 2019-03-15
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K/A 2019-03-15
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.